Polly E. Kintzel

1.4k total citations
28 papers, 890 citations indexed

About

Polly E. Kintzel is a scholar working on Pediatrics, Perinatology and Child Health, Oncology and Occupational Therapy. According to data from OpenAlex, Polly E. Kintzel has authored 28 papers receiving a total of 890 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pediatrics, Perinatology and Child Health, 7 papers in Oncology and 5 papers in Occupational Therapy. Recurrent topics in Polly E. Kintzel's work include Safe Handling of Antineoplastic Drugs (5 papers), Pharmaceutical studies and practices (5 papers) and Antifungal resistance and susceptibility (4 papers). Polly E. Kintzel is often cited by papers focused on Safe Handling of Antineoplastic Drugs (5 papers), Pharmaceutical studies and practices (5 papers) and Antifungal resistance and susceptibility (4 papers). Polly E. Kintzel collaborates with scholars based in United States and Poland. Polly E. Kintzel's co-authors include Timothy J. O’Rourke, Karim A. Calis, Laura Boehnke Michaud, Ted Eastlund, Elizabeth Clements, Gary H. Smith, Steven Gilmore, Alan Campbell, Alan F. List and Wendy Thomas and has published in prestigious journals such as Cancer Treatment Reviews, Drug Safety and Bone Marrow Transplantation.

In The Last Decade

Polly E. Kintzel

27 papers receiving 853 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Polly E. Kintzel United States 14 247 188 172 139 112 28 890
Marshall P. Goren United States 18 198 0.8× 368 2.0× 175 1.0× 131 0.9× 118 1.1× 35 797
Pentti Gröhn Finland 16 410 1.7× 157 0.8× 182 1.1× 55 0.4× 40 0.4× 50 1.1k
Rowena Schwartz United States 12 481 1.9× 107 0.6× 158 0.9× 205 1.5× 72 0.6× 34 1.7k
Biswajit Dubashi India 15 268 1.1× 73 0.4× 115 0.7× 135 1.0× 176 1.6× 131 883
Étienne Lemarié France 16 355 1.4× 92 0.5× 526 3.1× 75 0.5× 53 0.5× 31 1.5k
C. Astre France 18 250 1.0× 67 0.4× 165 1.0× 33 0.2× 70 0.6× 49 792
J.R. Trounce United Kingdom 14 105 0.4× 158 0.8× 76 0.4× 64 0.5× 79 0.7× 30 627
Stefano Mastrangelo Italy 23 259 1.0× 72 0.4× 199 1.2× 211 1.5× 125 1.1× 112 1.6k
Kyung Eob Choi United States 15 377 1.5× 108 0.6× 82 0.5× 49 0.4× 80 0.7× 26 775
Miguel Ángel Calleja‐Hernández Spain 19 256 1.0× 97 0.5× 159 0.9× 93 0.7× 20 0.2× 75 1.0k

Countries citing papers authored by Polly E. Kintzel

Since Specialization
Citations

This map shows the geographic impact of Polly E. Kintzel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Polly E. Kintzel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Polly E. Kintzel more than expected).

Fields of papers citing papers by Polly E. Kintzel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Polly E. Kintzel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Polly E. Kintzel. The network helps show where Polly E. Kintzel may publish in the future.

Co-authorship network of co-authors of Polly E. Kintzel

This figure shows the co-authorship network connecting the top 25 collaborators of Polly E. Kintzel. A scholar is included among the top collaborators of Polly E. Kintzel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Polly E. Kintzel. Polly E. Kintzel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kintzel, Polly E.. (2023). Elotuzumab: Empiric analysis of dexamethasone administration schedule. Journal of Oncology Pharmacy Practice. 30(1). 235–238.
2.
Kintzel, Polly E., et al.. (2018). Intravenous Lidocaine Administered as Twice Daily Bolus and Continuous Infusion for Intractable Cancer Pain and Wound Care Pain. Journal of Palliative Medicine. 22(3). 343–347. 6 indexed citations
3.
Kintzel, Polly E., et al.. (2018). Dose Rounding of Biologic and Cytotoxic Anticancer Agents: A Position Statement of the Hematology/Oncology Pharmacy Association. Journal of Oncology Practice. 14(3). e130–e136. 39 indexed citations
4.
Kintzel, Polly E., et al.. (2016). Cost avoidance from dose rounding biologic and cytotoxic antineoplastics. Journal of Oncology Pharmacy Practice. 23(5). 379–383. 14 indexed citations
5.
Kintzel, Polly E., et al.. (2014). Stability of i.v. admixture containing metoclopramide, diphenhydramine hydrochloride, and dexamethasone sodium phosphate in 0.9% sodium chloride injection. American Journal of Health-System Pharmacy. 71(23). 2061–2065. 2 indexed citations
6.
Kintzel, Polly E., Alan Campbell, Kathleen J. Yost, et al.. (2011). Reduced time for urinary alkalinization before high-dose methotrexate with preadmission oral bicarbonate. Journal of Oncology Pharmacy Practice. 18(2). 239–244. 14 indexed citations
7.
Kintzel, Polly E., et al.. (2011). Pseudohyperkalemia in a patient with chronic lymphoblastic leukemia and tumor lysis syndrome. Journal of Oncology Pharmacy Practice. 18(4). 432–435. 11 indexed citations
8.
Kintzel, Polly E., et al.. (2011). Clofarabine‐Associated Acute Kidney Injury and Proteinuria. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 31(9). 923–923. 9 indexed citations
9.
Clements, Elizabeth, et al.. (2010). Cost savings from dose rounding of biologic anticancer agents in adults. Journal of Oncology Pharmacy Practice. 17(3). 246–251. 35 indexed citations
10.
Kintzel, Polly E., et al.. (2009). Anticholinergic medications for managing noisy respirations in adult hospice patients. American Journal of Health-System Pharmacy. 66(5). 458–464. 22 indexed citations
11.
Peres, Edward, Polly E. Kintzel, Roger Dansey, et al.. (2008). Early intervention with antithrombin III therapy to prevent progression of hepatic venoocclusive disease. Blood Coagulation & Fibrinolysis. 19(3). 203–207. 24 indexed citations
12.
Kintzel, Polly E., et al.. (2008). Increased Risk of Metabolic Syndrome, Diabetes Mellitus, and Cardiovascular Disease in Men Receiving Androgen Deprivation Therapy for Prostate Cancer. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 28(12). 1511–1522. 83 indexed citations
13.
Kintzel, Polly E., et al.. (2006). Docetaxel‐Associated Epiphora. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 26(6). 853–867. 44 indexed citations
14.
Kintzel, Polly E., Ted Eastlund, & Karim A. Calis. (2003). Extracorporeal removal of antimicrobials during plasmapheresis. Journal of Clinical Apheresis. 18(4). 194–205. 25 indexed citations
15.
16.
Kintzel, Polly E.. (2001). Anticancer Drug???Induced Kidney Disorders. Drug Safety. 24(1). 19–38. 254 indexed citations
17.
Kintzel, Polly E.. (2001). Prophylaxis for Paclitaxel Hypersensitivity Reactions. Annals of Pharmacotherapy. 35(9). 1114–1117. 38 indexed citations
18.
Kintzel, Polly E.. (1995). Anticancer drug renal toxicity and elimination: dosing guidelines for altered renal function. Cancer Treatment Reviews. 21(1). 33–64. 196 indexed citations
19.
Kintzel, Polly E., et al.. (1994). Otic Administration of Amphotericin B 0.25% in Sterile Water. Annals of Pharmacotherapy. 28(3). 333–335. 2 indexed citations
20.
Kintzel, Polly E. & Gary H. Smith. (1992). Practical guidelines for preparing and administering amphotericin B. American Journal of Health-System Pharmacy. 49(5). 1156–1164. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marshall P. Goren Breakdown of academic impact, for papers by Pentti Gröhn Breakdown of academic impact, for papers by Rowena Schwartz Breakdown of academic impact, for papers by Biswajit Dubashi Breakdown of academic impact, for papers by Étienne Lemarié Breakdown of academic impact, for papers by C. Astre Breakdown of academic impact, for papers by J.R. Trounce Breakdown of academic impact, for papers by Stefano Mastrangelo Breakdown of academic impact, for papers by Kyung Eob Choi Breakdown of academic impact, for papers by Miguel Ángel Calleja‐Hernández
Rankless by CCL
2026